Jean-francois Henri Geschwind MD

Dr. Geschwind is Professor of Radiology, Surgery and Oncology and the Director of the Division of Vascular and Interventional Radiology at the Johns Hopkins University School of Medicine, and the Director of the Interventional Radiology Center at the Johns Hopkins Hospital. A native of France, Dr. Geschwind received his medical degree from Boston University School of Medicine in 1991. He completed his residency training as a Research Scholar (sponsored by the NIH) in Diagnostic Radiology at the University of California at San Francisco (UCSF) in 1996, where his research focused on cardiac magnetic resonance imaging. Dr. Geschwind completed his training in Vascular and Interventional Radiology at Johns Hopkins and joined the faculty in 1998 as an assistant professor. In 2002, he was appointed Director of the Division of Vascular and Interventional Radiology and of the Interventional Radiology Center at the Johns Hopkins Hospital, and in 2007 was promoted to Professor of Radiology, Surgery and Oncology at the Johns Hopkins University School of Medicine. As a Johns Hopkins faculty member, Dr Geschwind has focused his clinical expertise on treating hepatic cancer and other malignancies. He and his colleagues are currently working on a new approach using drugs designed to specifically block tumor metabolism in cancer cells.

This research was partially funded through an RO1 grant to Dr. Geschwind from the National Institutes of Health/National Cancer Institute. In 2008, he received a $1.4 million philanthropic donation to support his research in this field. In 2009, he founded a company based on this technology and has raised $4M towards the goal of starting Phase I clinical trials for liver cancer. Dr. Geschwind and colleagues have also continued to improve current therapies for patients with liver cancer, in particular catheter-based therapies such as chemoembolization and radioembolization. He is considered a key opinion leader in the field of liver cancer and has received numerous foundation, industry and federal grants for his research in the field. Dr. Geschwind was also Principal or Co-Investigator in over 40 clinical trials. A prolific speaker and lecturer on liver cancer, both nationally and internationally, Dr. Geschwind has delivered over 200 keynote speeches at scientific assemblies, annual meetings and symposia. He was visiting Professor at many prestigious institutions throughout the world such as MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Columbia University, University of Pennsylvania, Yonsei University and Seoul National University in Seoul, and Chinese University of Hong Kong; and gave the keynote address at many international conferences (India, Israel, Japan, Korea, China, Argentina, England, South Africa). In 2013, he gave the Annual Wilhelm Rontgen Lecture at the European Congress of Radiology in Vienna and the John Doppman Memorial Lecture at the National Institutes of Health. He was also inducted into the Academy of Radiology Research which is the most prestigious research organization in radiology.